David Allan

Ongoing research addresses the optimization of stem cell products used in hematopopietic stem cell transplantation and the translation of cell-based regenerative therapy into clinical practice. This includes analysis of how donor and stem cell product issues impact patients in Canada and research in knowledge synthesis of pre-clinical and clinical studies addressing the use of vascular progenitor cells, mesenchymal stromal cells, and extracellular vesicles in regenerative therapy.  Research in Dr. Allan’s program has been supported by CIHR, NSERC, Canadian Blood Services, The Ottawa Hospital Foundation and the Department of Medicine.

Research activities focus on hematopoietic stem cell donation, transplantation and biology and on translational research in cell-based regenerative therapy. My program has attracted medical trainees at all levels, graduate students and postgraduate fellows. We are working to bridge the gap between discoveries in the lab and making a difference for patients.